Skip to main content
OpenTrials

Clinical trial condition

Arthritis, Rheumatoid

Explore clinical trials studying Arthritis, Rheumatoid. Study availability and eligibility vary by location and protocol.

2,455 public trials 233 recruiting studies
Refine in advanced search Browse all conditions

Arthritis, Rheumatoid trial results

Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 17 locations
View Trial Details
Recruiting

Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

NCT07611747

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Arthritis, +31 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Universitario de Elche Elche, Alicante, Spain
  • Hospital Vega Baja de Orihuela Orihuela, Alicante, Spain
  • Hospital Universitario Vall d'Hebrón Barcelona, Spain
View all 17 locations
View Trial Details
Recruiting

A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

NCT07048197

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Brest, France
  • Novartis Investigative Site Le Kremlin-Bicêtre, France
  • Novartis Investigative Site Lille, France
View Trial Details
Recruiting

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

NCT06647069

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Investigational Site Number : 001-203 Brisbane, Queensland, Australia
  • Investigational Site Number : 001-201 Melbourne, Victoria, Australia
  • Investigational Site Number : 001-401 Sarajevo, Bosnia and Herzegovina
  • Investigational Site Number : 001-301 Auckland, New Zealand
View Trial Details
Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT06991114

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Artiva Investigational Site Tuscaloosa Tuscaloosa, Alabama, United States
  • Artiva Investigational Site Phoenix Phoenix, Arizona, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site Chula Vista Chula Vista, California, United States
View all 52 locations
View Trial Details

Related conditions